TOI offers a compelling but high-risk transformation story: a value-based oncology platform proving scalability through Florida profitability, rapid pharmacy-led growth, and improving cash flow, but still constrained by leverage and a critical 2027 debt maturity.
Overview
The Oncology Institute is a specialized value-based oncology platform operating more than 100 clinics and network locations across five states. It manages oncology care for roughly 2 million patients through patient services, specialty pharmacy, and clinical trials. TOI differentiates itself from traditional fee-for-service oncology by assuming delegated risk under capitated contracts, aiming to lower payer costs by 15%–20% while improving guideline adherence and care coordination. The model targets Medicare Advantage, Managed Medicaid, and commercial populations seeking community-based, lower-cost cancer care.